Tapicin

Tapicin Dosage/Direction for Use

piperacillin + tazobactam

Manufacturer:

Y.S.P. Industries

Distributor:

Y.S.P. Industries
Full Prescribing Info
Dosage/Direction for Use
Adults and children >12 years with normal renal function: Usual dosage: 4.5 g every 8 hours.
The total daily dosage depends on the severity and localization of the infection and can vary from 2.25-4.5 g administered every 6 or 8 hours.
Neutropenia: Recommended dose: 4.5 g every 6 hours in combination with aminoglycoside.
Neutropenic patients with signs of infection (eg. Fever) should receive immediately empirical antibiotic therapy before laboratory results are available.
Children: <12 years: This product is only recommended for the treatment of children with neutropenia.
Children weighing >50 kg: Follow adult dosing guideline. Including the aminoglycoside.
Children with normal renal function and weighing <50 kg: Adjust the dose to 90 mg/kg (80 mg piperacillin/10 mg tazobactam) administered every 6 hours in combination with an aminoglycoside.
Elderly: This product may be used at the same dose levels as adults except in cases of renal impairment.
Renal insufficiency: Adults and children weighing >50 kg: The IV dose should be adjusted to the degree of actual renal impairment. The suggested daily doses are as follows: (See Table 1.)

Click on icon to see table/diagram/image

Patients on haemodialysis: The maximum daily dose is 8 g/1 g. Because haemodialysis removes 30-50% of piperacillin in 4 hours, 1 additional dose of 2 g/250 mg should be administered following each dialysis period.
Patients with renal failure and hepatic insufficiency: Measurement of serum levels of Piperacillin/Tazobactam will provide additional guidance for adjusting dosage.
Adults and children weighing <50 kg: The IV dosage should be adjusted to the degree of actual renal impairment as follows: (See Table 2.)

Click on icon to see table/diagram/image

Children <50 kg on haemodialysis: The recommended dose is 45 mg/kg every 8 hours. Each patient must be monitored closely and dosage regimen to be adjusted accordingly.
Duration of therapy: Therapy is recommended to be a minimum of 5 days and maximum of 14 days, considering that dose administration should continue at least 48 hours after the resolution of clinical signs and symptoms or fever.
Mode of Administration:
This product may be given by slow IV injection (3-5 minutes) or by infusion (20-30 minutes).
Reconstitution: IV Injection: Each vial of 4.5 g or 2.25 g should be reconstituted with 20 ml or 10 ml of one of the reconstitution diluent respectively. Swirl until dissolved.
IV infusion: Each vial should be reconstituted with at least 20 ml of one of the reconstitution diluents. The reconstituted solution should be further diluted to the desired volume (50-150 ml) with one of the reconstitution diluents.
Reconstitution diluents: Water for injection (max volume used for each dose is 50 ml), 5% Dextrose injection, 0.9% Sodium Chloride injection.
This product does not contain preservative, therefore appropriate aseptic technique should be performed during preparation. Use the reconstituted solution immediately after preparation.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in